首页
热心肠日报
文献库
产业库
榜单
关于日报
《肠·道》演讲
往期精彩
《肠·道》2024
《肠·道》2023
《肠·道》2022
《肠·道》2021
《肠·道》2020
《肠·道》2019
《肠·道》2018
《肠·道》2017
关于《肠·道》
肠道大会
热心肠大会
热心肠智库
智库专家
专家动态
智库新闻
关于智库
奖学金
年度人物奖
更多
HOPE
会议信息
科学与艺术
学术专刊
R·AI
周刊
热心肠先生
研究院动态
关于我们
搜索
登录
关闭
手机邮箱登录
扫码登录
微信扫描二维码快捷登录
验证成功,将在
3
秒钟后跳转
已超时,请
重试
关闭
二维码登录
手机登录
邮箱登录
+86
+1
+852
+886
+81
+65
+61
+44
获取验证码
登录 / 注册
关闭
二维码登录
手机登录
邮箱登录
获取验证码
登录 / 注册
热心肠智库
专家文章 | 曹晓沧
2024
CA
Ferroptosis: A therapeutic opportunity of inflammatory bowel disease
Chin Med J, 10.1097/CM9.0000000000002998
CA
A tailored series of engineered yeasts for the cell-dependent treatment of inflammatory bowel disease by rational butyrate supplementation
Gut Microbes, 10.1080/19490976.2024.2316575
CA
The ERK-cPLA2-ACSL4 axis mediating M2 macrophages ferroptosis impedes mucosal healing in ulcerative colitis
FREE RAD BIOL ME, 10.1016/j.freeradbiomed.2024.02.016
CA
Ferroptosis: a promising candidate for exosome-mediated regulation in different diseases
CCS, 10.1186/s12964-023-01369-w
2023
CA
Selective oxidative protection leads to tissue topological changes orchestrated by macrophage during ulcerative colitis
Nat Commun, 10.1038/s41467-023-39173-2
点击查看热心肠日报解读
2022
CA
Breaking through the therapeutic ceiling of inflammatory bowel disease: Dual-targeted therapies
BIOMED PHARMACOTHER, 10.1016/j.biopha.2022.114174
CA
Genetic mutation and tumor microbiota determine heterogenicity of tumor immune signature: Evidence from gastric and colorectal synchronous cancers
Front Immunol, 10.3389/fimmu.2022.947080
FA
Modeling spatial interaction networks of the gut microbiota
Gut Microbes, 10.1080/19490976.2022.2106103
点击查看热心肠日报解读
CA
Evolutionary Insights Into Microbiota Transplantation in Inflammatory Bowel Disease
FCIMB, 10.3389/fcimb.2022.916543
CA
Positive Interventional Effect of Engineered Butyrate-Producing Bacteria on Metabolic Disorders and Intestinal Flora Disruption in Obese Mice
Microbiol Spectr, 10.1128/spectrum.01147-21
点击查看热心肠日报解读
FA
CA
Elective Switching on Biosimilars: Far More Than Nonmedical Switching
Inflamm Bowel Dis, 10.1093/ibd/izac007
2020
CA
Therapeutic potential of bicyclol in liver diseases: Lessons from a synthetic drug based on herbal derivative in traditional Chinese medicine
INT IMMUNOPHARMACOL, 10.1016/j.intimp.2020.107308
CA
Spatio-Temporal Metabolokinetics and Efficacy of Human Placenta-Derived Mesenchymal Stem/Stromal Cells on Mice with Refractory Crohn's-like Enterocutaneous Fistula
STEM CELL REV, 10.1007/s12015-020-10053-2
CA
Extracellular vesicles derived from human placental mesenchymal stem cells alleviate experimental colitis in mice by inhibiting inflammation and oxidative stress
INT J MOL MED, 10.3892/ijmm.2020.4679
FA
IGF-1C hydrogel improves the therapeutic effects of MSCs on colitis in mice through PGE-mediated M2 macrophage polarization
THERANOSTICS, 10.7150/thno.45434
FA
IGF-1C hydrogel improves the therapeutic effects of MSCs on colitis in mice through PGE 2-mediated M2 macrophage polarization
THERANOSTICS, 10.7150/thno.45434
FA
IGF-1C hydrogel improves the therapeutic effects of MSCs on colitis in mice through PGE 2-mediated M2 macrophage polarization
THERANOSTICS, 10.7150/thno.45434
FA
IGF-1C hydrogel improves the therapeutic effects of MSCs on colitis in mice through PGE 2-mediated M2 macrophage polarization
THERANOSTICS, 10.7150/thno.45434
CA
Therapeutic potential of genipin in various acute liver injury, fulminant hepatitis, NAFLD and other non-cancer liver diseases: More friend than foe
Pharmacol Res, 10.1016/j.phrs.2020.104945
CA
Engineered butyrate-producing bacteria prevents high fat diet-induced obesity in mice
Microb Cell Fact, 10.1186/s12934-020-01350-z